APAC CIO Outlook
  • Home
  • CXO Insights
  • CIO Views
  • Vendors
  • News
  • Conferences
  • Whitepapers
  • Newsletter
  • Awards
Apac
  • Agile

    AI Healthcare

    Artificial Intelligence

    Aviation

    Bi and Analytics

    Big Data

    Cloud

    Cyber Security

    Digital Infrastructure

    Digital Marketing

    Digital Transformation

    Digital Twin

    Drone

    Internet of Things

    Low Code No Code

    Networking

    Remote Work

    Startup

    Unified Communication

    Wireless

  • E-Commerce

    Education

    FinTech

    Healthcare

    Manufacturing

    Pharma and Life Science

    Retail

    Travel and Hospitality

  • Dell

    IBM

    Microsoft

    Salesforce

    SAP

  • Cognitive

    Compliance

    Contact Center

    Corporate Finance

    Data Center

    Data Integration

    Digital Asset Management

    Full Stack Development

    HR Technology

    IT Service Management

    Managed Services

    Procurement

    Proptech

    RegTech

Menu
    • Compliance
    • IBM
    • Big Data
    • Unified Communication
    • Digital Infrastructure
    • Data Center
    • Salesforce
    • MORE
    #

    Apac CIO Outlook Weekly Brief

    ×

    Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIO Outlook

    Subscribe

    loading

    THANK YOU FOR SUBSCRIBING

    • Home
    • News
    • Biotech
    Editor's Pick (1 - 4 of 8)
    left
    Framework of Three Horizons to Manage Current and Future Growth

    Clark Golestani, VP & CIO, Merck

    The Changing Role of CIO in the Biopharmaceutical Industry

    Andy Newsom, CIO, CSL Behring

    Formula Five For Biotech IT

    Jeffrey Keisling, CIO and SVP, Pfizer

    Finding Answers in R&D Data is a Team Sport

    Dan Hausman,

    Plant Biotechnology Success Requires Collaboration, Proactive Strategy

    Tim Hassinger, President and CEO, Dow AgroSciences

    The Biotech IT PMO 2.0

    Paul Ritchie,

    The Biotech CIO Roadmap in a Sea of Change

    Amit Shah, VP of IT- Enterprise Applications & Systems, Excelitas Technologies

    The Internet of Things in Healthcare:Smart Strategies to Deliver Better Value

    Miguel Louzan, VP-IT, UCB, Inc.

    right

    Malaysia Turns the Biotechnology Hub of Asia-Pacific

    Apac CIO Outlook | Thursday, September 26, 2019
    Tweet

    The adoption of Good Clinical and Good Manufacturing Practices ensure that Malaysia remains competitive as a research, development, and manufacturing destination, drawing more investments into the Biotechnology sector.

    FREMONT, CA: The ever-increasing scope for development in Biotechnology has made it a hot favorite for nations that are striving to build high income-driven economies. According to reports, the Biotechnology market is expanding at +9.9 percent CAGR and is expected to exceed USD 775 billion by 2024. The Chinese Biotechnology market alone was valued at USD 29.7 billion in 2017. Due to the leap in the number of chronic diseases, innovative technologies in the sector and increasing demand for bio-agriculture products, the Chinese Biotechnology market is expected to achieve a lucrative growth rate of 10.6 percent CAGR by 2024.

    Over the last eight years, Malaysia has been actively involved in strengthening its biotechnology ecosystem. By developing their local industries, they have a created a niche for themselves as a reputable Biotechnology hub of Asia. Malaysia's robust conducive environment combined with high growth potential provides multiple opportunities for the country's Biotechnology sector to develop to a fully-fledged state.

    Check Out : TOP BIOTECH STARTUPS IN APAC

    Strategic Advantages

    The country's rich biodiversity, cost-competitive skilled labor market, excellent transportation networks ICT infrastructure, strong government support, and public-private sector participation are leveraging the growth of Biotechnology sector there. Moreover, the cost-effective nature of the markets makes the country more inviting to do business.

    The adoption of Good Clinical and Good Manufacturing Practices ensure that Malaysia remains competitive as a research, development, and manufacturing destination, drawing more investments into the Biotechnology sector.

    Exploring new market territories

    New Biotechnology and Life Science companies looking to enter the market or companies looking to expand their market presence and sales reach, relish the Malaysian market due to the unique and developed trade linkages it proffers.

    As a signatory member of the Asean's Free Trade Area (FTA) agreement along with Japan, Korea, China, and New Zealand, Malaysia provides access to a regional market of over 500 million people. Also, the Islamic roots of the country help to access 'Halal' markets, especially in the Middle East.

    The BioNexus Program

    With the aid of Biotech Corp, the Malaysian government launched a program where it would recognize local and international biotechnology companies that would make them eligible for financial incentives and guarantees. This program has attracted foreign investments from Australia, China, Germany, Singapore, India, UK, and the US. Over 225 companies have been awarded the BioNexus status since 2013, with an approved total investment of MR 3.2 billion.

    The Commercialization Phase

    After a successful capacity building phase, Malaysia now has its focus on the construction of a strong foundation to create and commercialize the science to business. As part of the next stage, companies have already begun focusing on converting R&D ideas into products and services, creating more opportunities for profit.

    tag

    Biotechnology

    Startups

    Financial

    Weekly Brief

    loading
    ON THE DECK

    Digital Twin 2022

    Top Vendors

    E-Commerce 2022

    Top Vendors

    Previous Next

    I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

    Read Also

    Achieving Business Agility

    Key Challenges Facing Real-time Data Processing in Data Centers

    Digital Transformation Agility

    Angela Lam, CIO Shell Australia, COG & Integrated Gas, Shell (NYSE: SHEL)

    Technology Trends Impacting Digital Infrastructure in 2022

    The Benefits of Portable Solar Generators for Cities

    Agile Culture -The Path To Business Success

    Loading...

    Copyright © 2022 APAC CIOoutlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy and Anti Spam Policy 

    |  Sitemap |  Subscribe |   About us

    follow on linkedinfollow on twitter follow on rss
    This content is copyright protected

    However, if you would like to share the information in this article, you may use the link below:

    https://www.apacciooutlook.com/news/malaysia-turns-the-biotechnology-hub-of-asiapacific-nwid-6952.html